Champions Oncology
CSBR
38 hedge funds and large institutions have $60.1M invested in Champions Oncology in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 10 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 11
27% more capital invested
Capital invested by funds: $47.2M → $60.1M (+$12.9M)
0.19% more ownership
Funds ownership: 52.61% → 52.8% (+0.19%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less funds holding
Funds holding: 45 → 38 (-7)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
+$1.5M |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$897K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$686K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$635K |
| 5 |
BPI
Battery Partners IX
Boston,
Massachusetts
|
+$581K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.49M |
| 2 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$899K |
| 3 |
Renaissance Technologies
New York
|
-$474K |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$398K |
| 5 |
Squarepoint
New York
|
-$185K |
CSBR Hedge Fund Activity: Q1 2019 in Review
38 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q1 2019, worth a combined $60.1M — up 27% from $47.2M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CSBR and 3 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 15 added.
The largest buyer was Cadence Capital Management, adding an estimated $1.5M. The largest seller was EAM Investors, cutting an estimated $1.49M.
- 38 institutional investors held Champions Oncology (CSBR) as of Q1 2019, down from 45 in Q4 2018.
- Funds reported $60.1M of Champions Oncology stock for Q1 2019, up 27% quarter-over-quarter.
- 3 funds opened new Champions Oncology positions in Q1 2019 and 10 closed out, a net change of -7 holders.
- The largest Champions Oncology buyer in Q1 2019 was Cadence Capital Management, an estimated $1.5M added.
- The largest Champions Oncology seller in Q1 2019 was EAM Investors, an estimated $1.49M sold.
Based on aggregated 13F filings for Q1 2019.